dopexamine has been researched along with Heart Failure in 37 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (62.16) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Stylianakis, GE; Tagarakis, GI; Tsilimingas, NB | 1 |
| Martin, C; Papazian, L; Perrin, G | 1 |
| Blake, DW; McGrath, BP; Trigg, L; Way, D | 1 |
| Rogers, BW; Sziszak, TJ; Sziszak, TL; Taylor, BJ | 1 |
| Asanoi, H; Ishimura, T; Kinoshita, M; Lee, JD; Mitsudo, K; Morioka, S; Sakurai, T; Sasayama, S; Sato, H; Yoshikawa, J | 1 |
| Smit, AJ | 1 |
| Bittner, H; Filcek, S; Friedel, N; Hetzer, R; Kuppe, H; Matheis, G; Wenzel, R | 1 |
| Elkayam, U; Gollub, SB; Haffey, KA; Miller, LW; Young, JB | 1 |
| Böhm, M; Erdmann, E; Reuschel-Janetschek, E | 1 |
| Bristow, MR; Gilbert, EM; Ginsburg, R; Hershberger, RE; Larrabee, P; Mealey, P; Murray, J; Port, JD; Volkman, K | 1 |
| Baumann, G; Felix, SB; Filcek, SA | 1 |
| Baumann, G; Blömer, H; Gerzer, R; Kerscher, M; Stangl, K; Weil, J | 1 |
| van Zwieten, PA | 1 |
| Littler, WA; Murray, RG; Tan, LB | 2 |
| Bayliss, J; Poole-Wilson, P; Thomas, L | 1 |
| Bass, AS; Goldberg, LI; Kohli, JD; Murphy, MB | 1 |
| Böhm, M; Erdmann, E; Kemkes, B; Klövekorn, WP; Pieske, B; Schnabel, P; Schwinger, R | 1 |
| Campese, V; Elkayam, U; Hovanessian, L; Jamison, M; Rahimtoola, SH; Vasquez, J; Weber, L; Widerhorn, J | 1 |
| Drexler, H; Just, H; Meinertz, T | 1 |
| Leier, CV | 1 |
| Kahn, RJ; Reuse, C; Vincent, JL | 1 |
| Borow, KM; Carroll, JD; Ghali, J; Lang, RM; Murphy, MB; Neumann, A; Rajfer, SI; Weinert, L | 1 |
| Foulds, R; Jaski, BE; Serruys, PW; Wijns, W | 1 |
| Erhardt, L; Sjögren, A; Svensson, G | 1 |
| Dhainaut, JF | 1 |
| Binkley, PF; Carpenter, J; Leier, CV; Randolph, PH; Unverferth, DV | 1 |
| Hampton, JR; Murphy, JJ | 1 |
| Foulds, RA | 1 |
| Erhardt, L; Lindvall, B; Strandberg, LE; Svenson, G | 1 |
| Chatterjee, K; De Marco, T; Kwasman, M; Lau, D | 1 |
| Colardyn, FA; Vandenbogaerde, JF | 1 |
| Jaski, BE; Peters, C | 1 |
| Emmot, WW; Gollub, SB; Hassanein, K; Johnson, DE; Sights, KA; Vacek, JL; Wilson, DB | 1 |
| Dawson, JR; Jenkins, BS; Juul, SM; Signy, M; Thompson, DS; Turnbull, P; Webb-Peploe, MM | 1 |
5 review(s) available for dopexamine and Heart Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Dopexamine after heart surgery: an uncommonly used, though useful inotropic agent.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dopamine; Heart Failure; Humans; Splanchnic Circulation; Vasodilation | 2010 |
[Dopexamine: a new dopaminergic agonist].
Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation | 1993 |
Dopamine in heart failure and critical care.
Topics: Cardiotonic Agents; Controlled Clinical Trials as Topic; Critical Care; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; Heart Failure; Hemodynamics; Humans; Treatment Outcome | 2000 |
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Topics: Adrenergic Agonists; Animals; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Nitroprusside | 1989 |
7 trial(s) available for dopexamine and Heart Failure
| Article | Year |
|---|---|
Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study.
Topics: Acute Disease; Adult; Aged; Dopamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Substance Withdrawal Syndrome; Vasodilator Agents | 1995 |
Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
Topics: Adrenergic Agonists; Dopamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1991 |
[Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Topics: Adrenergic beta-Agonists; Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Clinical Trials as Topic; Cyclic GMP; Dopamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1990 |
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Topics: Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasodilator Agents | 1991 |
Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Topics: Adult; Aged; Cardiac Output; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Random Allocation; Receptors, Adrenergic; Receptors, Dopamine; Renal Circulation | 1989 |
Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
Topics: Adrenergic Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Output, Low; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renal Circulation; Stroke Volume; Vascular Resistance | 1988 |
Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects.
Topics: Cardiovascular System; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation; Heart Failure; Hemodynamics; Humans | 1988 |
25 other study(ies) available for dopexamine and Heart Failure
| Article | Year |
|---|---|
Regional blood flow effects of dopexamine versus enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure.
Topics: Anesthesia; Animals; Blood Pressure; Cardiac Output; Dopamine; Doxorubicin; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Hindlimb; Kidney; Propofol; Rabbits; Regional Blood Flow; Vasodilator Agents | 1994 |
Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
Topics: Animals; Animals, Newborn; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart; Heart Failure; Hemodynamics; Infusions, Intravenous; Isoproterenol; Myocardium; Oxygen Consumption; Propranolol; Receptors, Adrenergic, beta; Sheep; Vasodilator Agents | 1993 |
Haemodynamic effects of different doses of dopexamine hydrochloride in low cardiac output states following cardiac surgery.
Topics: Adrenergic Agonists; Adult; Aged; Aortic Valve; Cardiac Output, Low; Coronary Artery Bypass; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Postoperative Complications | 1992 |
Lack of sustained hemodynamic effects of the beta 2-adrenoceptor agonist dopexamine in end-stage congestive heart failure.
Topics: Adrenergic beta-Agonists; Adult; Dopamine; Heart Failure; Hemodynamics; Humans; Middle Aged | 1990 |
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Ethanolamines; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stimulation, Chemical | 1990 |
Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Time Factors; Urine | 1990 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents | 1987 |
Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure.
Topics: Adrenergic beta-Agonists; Aged; Cardiac Output, Low; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Norepinephrine | 1987 |
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug.
Topics: Adrenergic Agonists; Animals; Dogs; Dopamine; Electric Stimulation; Heart; Heart Failure; Infusions, Intravenous; Male; Myocardial Contraction; Neurotransmitter Uptake Inhibitors; Norepinephrine | 1989 |
Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Topics: Adenylyl Cyclases; Adrenergic Agonists; Adrenergic beta-Antagonists; Binding, Competitive; Dopamine; Female; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Propanolamines; Receptors, Adrenergic, beta | 1989 |
Dopexamine in cardiorespiratory failure. Commentary on drug research in the critically ill.
Topics: Adrenergic Agonists; Dopamine; Heart Failure; Humans | 1989 |
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure.
Topics: Adrenergic Agonists; Aged; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Respiratory Tract Infections | 1989 |
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
Topics: Adult; Dopamine; Female; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Stress, Mechanical; Systole | 1988 |
The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Dopamine; Drug Evaluation; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Dopamine; Vascular Resistance | 1986 |
Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
Topics: Adrenergic Agonists; Adult; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
A symposium: Focus on heart failure--current experiences in basic research and clinical studies on dopexamine hydrochloride (Dopacard). September 12-13, 1987, Paris, France. Proceedings.
Topics: Adrenergic Agonists; Animals; Dopamine; Heart Failure; Humans | 1988 |
Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
Topics: Adrenergic Agonists; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged | 1988 |
Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
Topics: Aged; Dopamine; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Vasodilator Agents | 1988 |
Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Dopamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Norepinephrine | 1988 |
Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
Topics: Aged; Analysis of Variance; Cardiac Output; Critical Care; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1988 |
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Topics: Blood Pressure; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Norepinephrine; Vascular Resistance; Vasodilation | 1988 |
Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
Topics: Adult; Aged; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1988 |
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
Topics: Adult; Aged; Blood Flow Velocity; Chemical Phenomena; Chemistry; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume; Vascular Resistance | 1985 |